Gopinathan Suma 4

What Happened
Suma Gopinathan, Senior Vice President, Discovery at Lexicon Pharmaceuticals (LXRX), had restricted stock units (RSUs) convert into 99,950 shares on February 28, 2026. The company withheld 24,338 of those shares to satisfy tax withholding obligations at $1.47 per share, a withholding value of $35,777, leaving a net delivery of 75,612 shares to the insider. The filing records the transactions as conversion/exercise of derivatives (code M) and tax withholding (code F).

Key Details

• Transaction date: February 28, 2026; Form 4 filed March 3, 2026 (no late filing flag shown).
• RSUs converted: 14,000 + 20,310 + 65,640 = 99,950 shares (three separate grant tranches).
• Shares withheld for taxes: 24,338 shares at $1.47 each = $35,777. Net shares received: 75,612.
• Transaction codes: M = exercise/conversion of derivative (conversion of RSUs to common stock); F = payment of tax liability via share withholding.
• Footnotes: F1 clarifies an RSU equals a contingent right to one common share; F2 confirms company withheld shares to satisfy tax withholding; F3 notes these RSUs vest 1/3 on Feb 28 in each of the three years following grant (this appears to be a scheduled vesting event).
• Shares owned after transaction: not specified in the provided filing excerpt.

Context
This was a scheduled RSU vesting/conversion event, not an open-market sale or purchase. The company’s withholding of shares to cover tax obligations is a routine administrative action and should not be interpreted as a market-sale by the insider. For retail investors, purchases are typically a stronger bullish signal; this is a vesting event converting deferred compensation into stock.